Catalyst
Slingshot members are tracking this event:
Theravance Biopharma (TBPH) plans to initiate phase 1 study of IND candidate TD-1473 for treatment of ulcerative colitis in early 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| TBPH |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 10, 2015
Occurred Source:
http://investor.theravance.com/releasedetail.cfm?ReleaseID=946494
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1, Ind, Td-1473, Ulcerative Colitis
